TNFα-induced MUC4 elicits trastuzumab resistance in ErbB-2-positive breast cancer

被引:0
|
作者
Mercogliano, Maria F. [1 ]
De Martino, Mara [1 ]
Venturutti, Leandro [1 ]
Rivas, Martin A. [2 ]
Inurrigarro, Gloria [3 ]
Frahm, Isabel [3 ]
Proietti, Cecilia J. [1 ]
Izzo, Franco [1 ]
Elizade, Patricia V. [1 ]
Schillaci, Roxana [1 ]
机构
[1] IBYME CONICET, CABA, Buenos Aires, DF, Argentina
[2] Weill Cornell Med Coll, New York, NY USA
[3] Sanatorio Mater Dei, Serv Patol, CABA, Buenos Aires, DF, Argentina
关键词
D O I
10.1158/1538-7445.AM2015-712
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
712
引用
收藏
页数:2
相关论文
共 50 条
  • [41] MUC1* is a determinant of trastuzumab (Herceptin) resistance in breast cancer cells
    Shawn P. Fessler
    Mark T. Wotkowicz
    Sanjeev K. Mahanta
    Cynthia Bamdad
    Breast Cancer Research and Treatment, 2009, 118 : 113 - 124
  • [42] MUC1* is a determinant of trastuzumab (Herceptin) resistance in breast cancer cells
    Fessler, Shawn P.
    Wotkowicz, Mark T.
    Mahanta, Sanjeev K.
    Bamdad, Cynthia
    BREAST CANCER RESEARCH AND TREATMENT, 2009, 118 (01) : 113 - 124
  • [43] Immunohistochemical analysis of the PTEN-and Muc4-associated Her2/neu of breast cancer resistance to trastuzumab
    Khamidullina, G.
    Sereda, E.
    Zharkov, N.
    VIRCHOWS ARCHIV, 2014, 465 : S92 - S93
  • [44] Early Trastuzumab Interruption and Recurrence-Free Survival in ERBB2-Positive Breast Cancer
    Copeland-Halperin, Robert S.
    Al-Sadawi, Mohammed
    Patil, Sujata
    Liu, Jennifer E.
    Steingart, Richard M.
    Dang, Chau T.
    Yu, Anthony F.
    JAMA ONCOLOGY, 2020, 6 (12) : 1971 - 1972
  • [45] MUC1 oncoprotein confers trastuzumab resistance in HER2-positive breast cancer cells by maintaining cancer stem cell phenotype
    Yin, Jun
    Sand, Andrea
    Piacsek, Mitchell
    Sun, Chaoyang
    Friedrich, Logan S.
    Rovin, Richard A.
    Tjoe, Judy A.
    CANCER RESEARCH, 2020, 80 (04)
  • [46] MUC4 Involvement in ErbB2/ErbB3 Phosphorylation and Signaling in Response to Airway Cell Mechanical Injury
    Theodoropoulos, George
    Carraway, Coralie A. Carothers
    Carraway, Kermit L.
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2009, 107 (01) : 112 - 122
  • [47] The MUC4 oncomucin mediates resistance of human pancreatic cancer cells to FOLFIRINOX drugs
    Skrypek, Nicolas
    Boukrout, Nihad
    Lahdaoui, Fatima
    Schulz, Celine
    Vasseur, Romain
    Duchene, Belinda
    Van Seuningen, Isabelle
    Jonckheere, Nicolas
    CANCER RESEARCH, 2016, 76
  • [48] Randomized Study of Lapatinib Alone or in Combination With Trastuzumab in Women With ErbB2-Positive, Trastuzumab-Refractory Metastatic Breast Cancer
    Blackwell, Kimberly L.
    Burstein, Harold J.
    Storniolo, Anna Maria
    Rugo, Hope
    Sledge, George
    Koehler, Maria
    Ellis, Catherine
    Casey, Michelle
    Vukelja, Svetislava
    Bischoff, Joachim
    Baselga, Jose
    O'Shaughnessy, Joyce
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (07) : 1124 - 1130
  • [49] MUC1 is a potential target to overcome trastuzumab resistance in breast cancer therapy
    Aysooda Hosseinzadeh
    Parnaz Merikhian
    Nazanin Naseri
    Mohammad Reza Eisavand
    Leila Farahmand
    Cancer Cell International, 22
  • [50] MUC1 is a potential target to overcome trastuzumab resistance in breast cancer therapy
    Hosseinzadeh, Aysooda
    Merikhian, Parnaz
    Naseri, Nazanin
    Eisavand, Mohammad Reza
    Farahmand, Leila
    CANCER CELL INTERNATIONAL, 2022, 22 (01)